Director Judd Buys Over $152K in LifeVantage Stock Following Q2 Decline
LFVN sits 19% above its 52-week low of $3.9.
Summary
Director Dayton Judd purchased over $152,000 worth of LifeVantage Corporation common stock in open market transactions, signaling confidence after the company's recent negative financial reports.
Key Events · Ownership and Investor Activity · LFVN
-
Director Initiates Significant Stock Purchase
Director Dayton Judd acquired 33,197 shares of LifeVantage common stock through open market purchases, increasing his direct holdings.
-
Substantial Investment Value
The total value of these transactions amounted to $152,422.11, executed across three separate purchases.
-
Timing Follows Negative Financial Reports
These purchases occurred between February 26 and March 2, 2026, following the company's Q2 2026 report on February 4, 2026, which detailed substantial revenue and net income declines and a CEO retirement.
Analysis · LFVN · Life Sciences
This significant open market purchase by Director Dayton Judd comes shortly after LifeVantage reported a substantial decline in Q2 revenue and net income, along with the announcement of a CEO retirement and a share repurchase program. Judd's acquisition of over $152,000 in shares, representing a notable portion of the company's market capitalization, suggests a vote of confidence from a board member amidst recent challenges. Investors may view this as a positive signal, indicating that at least one insider believes the stock is undervalued following the negative news.
At the time of this filing, LFVN was trading at $4.64 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $57.8M. The 52-week trading range was $3.90 to $17.64. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.